Company profile

Cilian is a biotechnology company that uses the unique abilities of Ciliates, a new class of production organisms, for the manufacturing at industrial scale of therapeutic proteins. Its production platform CIBEX is ideally suited for a range of viral vaccines; digestive and therapeutic enzymes; and monoclonal antibodies. Cilian is in a position to design the production process of those therapeutic proteins much more efficient, substantially safer and significantly more cost effective than other standard mammalian production methods. This should be technically and economically attractive to large pharma and biotech companies.